The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Evolution of Digital Technologies and Use of Virtual Assistants in Drug Development
Abstract
The drug development phase is one of the most time-consuming and expensive stages in the lifecycle of a drug. Marred by patent expirations, price regulations, complexities in disease conditions, life sciences companies are facing a daunting task to bring new molecular entities into the market. Digital health technologies are playing a critical role in addressing some of the challenges faced during drug development. In this chapter, the author talks about the challenges and key trends in the world of drug development, use of new digital health technologies, and the future of drug development. As an example, the author dives into a specific case study on the use of virtual assistants in clinical trials and the benefits of its usage on patients, healthcare professionals, and life sciences companies.
Related Content
Kakhaber Djakeli.
© 2024.
25 pages.
|
Nugzar Todua, Charita Jashi, Nia Todua.
© 2024.
16 pages.
|
Mohamad Zreik.
© 2024.
19 pages.
|
Agnieszka Jadwiga Wójcik-Czerniawska, Zbigniew Grzymała.
© 2024.
17 pages.
|
Aditya Prasad, Ashwani Panesar.
© 2024.
26 pages.
|
Iza Gigauri.
© 2024.
12 pages.
|
V. Sangeetha, A. Mamatha, M. Vaneeta, K. Beena.
© 2024.
15 pages.
|
|
|